Evonik’s customer magazine for the feed and livestock production industries.
The Health & Nutrition Business Unit of Evonik Industries, Essen (Germany), has now published the latest edition of its customer magazine AMINONews® for the compound feed and livestock production industries.
This edition focuses on the topic of sustainability. The contribution “Healthy and environmentally sustainable food production” written by Dr. Michael Binder presents the results of the most recent amino acid life cycle analysis carried out within Evonik.
The other two articles around sustainability are:
- “Can sustainable livestock production be achieved”, by Dr. Artur Müller and Dr. Mark Redshaw
- “Evaluating the environmental impact of nutritional strategies with AMINOFootprint®”, by Dr. Mark Redshaw
Featuring as “Research Highlights”, the magazine also reports on current developments and latest scientific publications on amino acids for animal nutrition.
Evonik is the only company in the world that produces and markets all four essential amino acids used in advanced animal nutrition: MetAmino® (DL-Methionine), Biolys® (L-Lysine), ThreAmino® (L-Threonine) and TrypAmino® (L-Tryptophan). The company markets innovative products and services in more than one hundred countries and thus makes a valuable contribution to the cost-efficiency of its customers and to healthy and environment-friendly animal nutrition.
Evonik is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, it has energy and residential real estate operations. Our performance is shaped by creativity, specialization, reliability and continuous self-renewal.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.